# Early-Start Antiplatelet Treatment After Neurosurgery in Patients With Spontaneous Intracerebral Hemorrhage

> **NCT04820972** · NA · COMPLETED · sponsor: **Beijing Tiantan Hospital** · enrollment: 269 (actual)

## Conditions studied

- Spontaneous Intracerebral Hemorrhage

## Interventions

- **DRUG:** Antiplatelet Agents

## Key facts

- **NCT ID:** NCT04820972
- **Lead sponsor:** Beijing Tiantan Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-01
- **Primary completion:** 2023-02-01
- **Final completion:** 2023-05-01
- **Target enrollment:** 269 (ACTUAL)
- **Last updated:** 2025-04-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04820972

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04820972, "Early-Start Antiplatelet Treatment After Neurosurgery in Patients With Spontaneous Intracerebral Hemorrhage". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04820972. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*